This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
GE HealthCare's Shares Rise After the Launch of Versana Premier
by Zacks Equity Research
GEHC launches Versana Premier, an AI-powered ultrasound system with advanced features designed for efficient, high-quality diagnostics across multiple specialties.
DGXNegative Net Change ADUSNegative Net Change RDNTNegative Net Change GEHCPositive Net Change
medical medical-devices
WBA Stock Up on Q4 Earnings & Revenues Beat, Unveils Strategic Action
by Zacks Equity Research
Walgreens reports better-than-expected earnings and revenues in the fourth quarter of fiscal 2024.
PAHCNegative Net Change HQYNegative Net Change WBAPositive Net Change VCYTNegative Net Change
earnings medical medical-devices
After Golden Cross, HCI Group (HCI)'s Technical Outlook is Bright
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
HCINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is a Surprise Coming for Abbott (ABT) This Earnings Season?
by Zacks Equity Research
Abbott (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ABTNegative Net Change
medical medical-devices
SIBN Stock Up After First-In-Patient Use of FDA Breakthrough Device
by Zacks Equity Research
SI-BONE aims to address the unmet clinical needs of complex pelvic fragility fractures by providing a solution that improves both surgical efficiency and patient recovery.
BSXPositive Net Change BAXNegative Net Change DVANegative Net Change SIBNPositive Net Change
medical medical-devices
PacBio Shares Rise After NCCS Partnership for Cancer Genomics Research
by Zacks Equity Research
PACB partners with NCCS to enhance cancer research using the Onso short-read platform and Revio long-read sequencing, advancing precision oncology in Singapore and Asia.
DGXNegative Net Change RDNTNegative Net Change PACBPositive Net Change AVAHNegative Net Change
medical medical-devices
Abbott's Q3 Earnings Release Coming Up, EPD Business in Focus
by Zacks Equity Research
ABT's Neuromodulation growth is expected to have been driven by strong demand in international markets for the Eterna rechargeable spinal cord stimulation device.
ABTNegative Net Change MASIPositive Net Change RDNTNegative Net Change ACADNegative Net Change
earnings medical-devices
DGX Gears Up for Q3 Earnings: What Lies Ahead for the Stock?
by Zacks Equity Research
Quest Diagnostics is expected to deliver robust base business growth in the third quarter of 2024.
DGXNegative Net Change MASIPositive Net Change RDNTNegative Net Change ACADNegative Net Change
earnings medical medical-devices
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock
by Zacks Equity Research
LH is expected to perform strongly in both of its segments and will also likely advance in its strategic priorities.
LHNegative Net Change MASIPositive Net Change RDNTNegative Net Change ACADNegative Net Change
earnings medical medical-devices
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe
by Zacks Equity Research
ATRC's EnCompass Clamp receives a CE Mark, enabling European surgeons to access faster, simpler heart ablation in cardiac surgeries with advanced radiofrequency technology.
BSXPositive Net Change MDTNegative Net Change ATRCNegative Net Change GEHCPositive Net Change
medical medical-devices
GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business
by Zacks Equity Research
GEHC acquires clinical AI business to aid its ultrasound portfolio with AI-driven image analysis tools.
MDTNegative Net Change SYKNegative Net Change MDRXNegative Net Change GEHCPositive Net Change
medical medical-devices
MYGN Taps Ultima Genomics' UG 100 Platform for Advanced Clinical Tests
by Zacks Equity Research
Myriad Genetics and Ultima Genomics to explore the latter's sequencing platform for advanced clinical tests in oncology and reproductive genomics.
LHNegative Net Change TMONegative Net Change ILMNNegative Net Change MYGNNegative Net Change
medical medical-devices
OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies
by Zacks Equity Research
OPKO Health's receipt of the additional funding from BARDA is expected to explore the MSTAR platform to prepare for outbreaks and respond rapidly to emerging viral threats.
ILMNNegative Net Change QGENNegative Net Change OPKNegative Net Change PACBPositive Net Change
medical medical-devices
SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System
by Zacks Equity Research
Smith & Nephew introduces the LEGION Hinged Knee System with OXINIUM Technology, elevating knee revision surgery through innovation.
MDTNegative Net Change SYKNegative Net Change SNNNegative Net Change ZBHNegative Net Change
medical medical-devices
Alignment HealthCare Partners With Intermountain Health in Nevada
by Zacks Equity Research
ALHC partners with Intermountain Health to enhance access to high-quality care for Medicare members in Clark and Washoe counties, starting Jan 2025.
HQYNegative Net Change CODXNegative Net Change ALHCPositive Net Change ICCMNegative Net Change
medical medical-devices
GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod
by Zacks Equity Research
GE Healthcare's MIM Software announces the FDA clearance of Monte Carlo Dosimetry for Theranostics, enhancing precision in personalized treatment plans.
HOLXNegative Net Change FUJIYNegative Net Change BFLYNegative Net Change GEHCPositive Net Change
medical medical-devices
RVTY's Latest Launch to Enable APOE Genotyping of Alzheimer's Disease
by Zacks Equity Research
Revvity's latest solution for specific typing of AD-associated APOE gene is likely to allow assessment of a patient's risk for adverse effects from new anti-amyloid therapy for Alzheimer's.
BIIBNegative Net Change LLYNegative Net Change ITCINegative Net Change RVTYNegative Net Change
medical medical-devices
Should You Buy Roku (ROKU) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ROKUNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent
by Zacks Equity Research
NSPR gains premarket approval for its CGuard Prime carotid stent system for use in United States for treating carotid artery stenosis.
BSXPositive Net Change MDTNegative Net Change NSPRNegative Net Change GEHCPositive Net Change
medical medical-devices
CRL to Aid Lundbeck's Neurological Drug Research With AI-Backed Logica
by Zacks Equity Research
Charles River and Lundbeck sign an agreement to use Logica to advance the discovery of novel neurological drugs.
ABTNegative Net Change BSXPositive Net Change MDTNegative Net Change CRLNegative Net Change
medical medical-devices
MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?
by Urmimala Biswas
The latest rate cut should help Medtronic expand in the AFib, structural heart, robotics, neuromodulation, hypertension and diabetes markets.
ABTNegative Net Change BSXPositive Net Change BDXNegative Net Change MDTNegative Net Change
medical medical-devices
CAH Stock May Gain Following the Distribution Deal With T2 Biosystems
by Zacks Equity Research
Cardinal Health and T2 Biosystems announce an agreement selecting the former to sell direct-from-blood diagnostics for the rapid detection of sepsis-causing pathogens.
BSXPositive Net Change CAHPositive Net Change INSPNegative Net Change TMDXPositive Net Change
medical medical-devices
Amwell Shares Rise After Expansion of Portfolio With Hello Heart
by Zacks Equity Research
AMWL adds Hello Heart to its clinical programs, offering heart health solutions to members with high blood pressure or cholesterol via its Converge platform.
DGXNegative Net Change RDNTNegative Net Change RMTINegative Net Change AMWLNegative Net Change
medical medical-devices
Integer Holdings (ITGR) Gains 30.5% YTD: What's Driving the Stock?
by Zacks Equity Research
Integer Holdings (ITGR) shares gain on the back of growth in the Medical segment. However, fluctuations in raw material prices and the oil and energy market are concerning.
BSXPositive Net Change ITGRNegative Net Change INSPNegative Net Change TMDXPositive Net Change
medical medical-devices
DaVita Stock Gains 47.3% Year to Date: What's Behind the Rally?
by Zacks Equity Research
DVA's strong performance and growth strategies, including patient-centric care and international expansion, position it well for continued success despite potential risks.
DGXNegative Net Change DVANegative Net Change RDNTNegative Net Change RMTINegative Net Change
medical medical-devices